Core Viewpoint - Fujifilm Holdings Corporation reported strong financial performance for the first quarter of the fiscal year 2025, with both sales revenue and operating profit reaching historical highs for the same period [1]. Financial Performance - Sales revenue for the first quarter was 749.5 billion yen, a year-on-year increase of 0.1% [1]. - Operating profit rose by 21.1% year-on-year to 75.3 billion yen [1]. - The imaging segment saw a significant sales revenue increase of 11.2%, reaching 145.3 billion yen, with operating profit up 28.4% to 41.8 billion yen [1]. Business Segments - The strong growth in the Bio CDMO, semiconductor materials, and imaging business segments contributed to the overall excellent performance in the first quarter [1]. - The medical health business reported sales revenue of 228.5 billion yen, a slight decrease of 2.9% year-on-year, but operating profit increased by 20.7% to 4.3 billion yen [4]. - The electronic materials business had sales revenue of 102.1 billion yen, a minor decline of 0.9%, while operating profit rose by 13% to 22.5 billion yen [4]. - The commercial innovation business reported sales revenue of 273.6 billion yen, down 2.3%, but operating profit increased by 7.9% to 15.6 billion yen [4]. Market Trends - The "peel-apart film" gained popularity due to endorsements from celebrities, leading to a surge in demand and prices for related products [2][3]. - The official price for Fujifilm Instax mini film is 7,200 yen for 20 sheets, but due to limited production, prices in the second-hand market have increased significantly [4]. Future Outlook - The company maintains its full-year performance forecast for fiscal year 2025, expecting sales revenue of 3.28 trillion yen, operating profit of 331 billion yen, and net profit attributable to Fujifilm Holdings of 262 billion yen [4].